Skip to content

Author

Ying-Bei Chen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Phase II Study of an Androgen Receptor Pathway Inhibitor + Atezolizumab + Gonadotropin-Releasing Hormone Analog and Stereotactic Body Radiotherapy in Hormone-Sensitive Metastatic Prostate Cancer

Metastatic androgen pathway modulation–sensitive (mAPMS) prostate cancer is generally immunologically cold. Emerging data suggest radiotherapy and androgen-deprivation therapy (ADT) augment the antitumor immune response to immune checkpoint blockade. We evaluated the efficacy and safety of atezolizumab combined wit...

M. Dallos, Mark N. Stein, I. Deutsch et al. · 0 citations
Open access Aug 2026

Developmental reversion underlies resistance to immune checkpoint blockade in kidney cancer

An atlas of ccRCC tumors is assembled combining single-cell RNA sequencing and imaging-based spatial transcriptomics to suggest reversion to embryonic nephrogenesis as a defining feature of persister cells in ccRCC, nominating the nephrogenic developmental program and its associated inhibitory checkpoint repertoire as...

Dig V.K. Yarlagadda, Zhenghan Wang, Hui Jiang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.